GO
Loading...

Questcor: One-Drug Wonder

Thursday, 17 Nov 2011 | 6:45 PM ET

Questcor is a rare growth biotech, says Mad Money's Cramer, with a spectacular 42% growth rate, selling at 23 times earnings. Discussing the company's outlook, with Donald Bailey, Questcor Pharmaceuticals, Inc. CEO.